Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'ROTHMAN RB' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 166 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ulrich, T; Dersch, CM; Rothman, RB; Jacobson, AE; Rice, KC
      Derivatives of 17-(2-methylallyl)-substituted noroxymorphone: Variation ofthe delta address and its effects on affinity and selectivity for the delta opioid receptor

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    2. Baumann, MH; Ayestas, MA; Dersch, CM; Rothman, RB
      1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain

      NEUROPSYCHOPHARMACOLOGY
    3. Xu, H; Lu, YF; Thomas, JB; Carroll, FI; Rice, KC; Rothman, RB
      Opioid peptide receptor studies. 15. Relative efficacy of 4-[(N-allyl-3-methyl-4 piperidinyl) phenylamino]-N,N-diethylbenzamide and related compoundsat the cloned human delta-opioid receptor

      SYNAPSE
    4. Rothman, RB; Baumann, MH; Dersch, CM; Romero, DV; Rice, KC; Carroll, FI; Partilla, JS
      Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

      SYNAPSE
    5. Xu, H; Hashimoto, A; Rice, KC; Jacobson, AE; Thomas, JB; Carroll, FI; Lai, J; Rothman, RB
      Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [S-35]GTP-gamma-S functional binding assay

      SYNAPSE
    6. Xu, H; Lu, YF; Rice, KC; Ananthan, S; Rothman, RB
      SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [S-35]-GTP-gamma-S binding at cloned opioid receptors

      BRAIN RESEARCH BULLETIN
    7. Pepper, JP; Baumann, MH; Ayestas, M; Rothman, RB
      Inhibition of MAO-A fails to alter cocaine-induced increases in extracellular dopamine and norepinephrine in rat nucleus accumbens

      MOLECULAR BRAIN RESEARCH
    8. Baumann, MH; Rothman, RB; Pablo, JP; Mash, DC
      In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    9. McLamore, S; Ullrich, T; Rothman, RB; Xu, H; Dersch, C; Coop, A; Davis, P; Porreca, F; Jacobson, AE; Rice, KC
      Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5 alpha-epoxy-3,14-dihydroxy-6,7 : 2 ',3 '-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy

      JOURNAL OF MEDICINAL CHEMISTRY
    10. Thomas, JB; Herault, XM; Rothman, RB; Atkinson, RN; Burgess, JP; Mascarella, SW; Dersch, CM; Xu, H; Flippen-Anderson, JL; George, CF; Carroll, FI
      Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl) arylamino]-N,N-diethylbenzamides

      JOURNAL OF MEDICINAL CHEMISTRY
    11. Zhang, Y; Joseph, DB; Bowen, WD; Flippen-Anderson, JL; Dersch, CM; Rothman, RB; Jacobson, AE; Rice, KC
      Synthesis and biological evaluation of tropane-like 1-{2-[bis(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl) piperazine (GBR 12909) analogues

      JOURNAL OF MEDICINAL CHEMISTRY
    12. Thomas, JB; Atkinson, RN; Rothman, RB; Fix, SE; Mascarella, SW; Vinson, NA; Xu, H; Dersch, CM; Lu, YF; Cantrell, BE; Zimmerman, DM; Carroll, FI
      Identification of the first trans-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity

      JOURNAL OF MEDICINAL CHEMISTRY
    13. Yu, H; Rothman, RB; Dersch, CM; Partilla, JS; Rice, KC
      Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters

      BIOORGANIC & MEDICINAL CHEMISTRY
    14. Thomas, JB; Atkinson, RN; Rothman, RB; Burgess, JP; Mascarella, SW; Dersch, CM; Xu, H; Carroll, FI
      4-[(8-alkyl-8-azabicyclo[3.2.1]octyl-3-yl)-3-arylanilino]-N,N-diethylbenzamides: High affinity, selective ligands for the delta opioid receptor illustrate factors important to antagonist activity

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    15. Baumann, MH; Ayestas, MA; Dersch, CM; Brockington, A; Rice, KC; Rothman, RB
      Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: Therapeutic implications

      SYNAPSE
    16. Rothman, RB; Partilla, JS; Baumann, MH; Dersch, CM; Carroll, FI; Rice, KC
      Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: A pharmacological strategyfor treating stimulant abuse

      SYNAPSE
    17. Rothman, RB; Gorelick, DA; Heishman, SJ; Eichmiller, PR; Hill, BH; Norbeck, J; Liberto, JG
      An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence

      JOURNAL OF SUBSTANCE ABUSE TREATMENT
    18. Baumann, MH; Rothman, RB; Ali, SF
      Comparative neurobiological effects of ibogaine and MK-801 in rats

      DRUG AND ALCOHOL DEPENDENCE
    19. Partilla, JS; Dersch, CM; Yu, H; Rice, KC; Rothman, RB
      Neurochemical neutralization of amphetamine-type stimulants in rat brain by the indatraline analog (-)-HY038

      BRAIN RESEARCH BULLETIN
    20. Heyliger, SO; Ni, Q; Rothman, RB
      Resolution of two [S-35]GTP-gamma-S binding sites and their response to chronic morphine treatment: A binding surface analysis

      BRAIN RESEARCH BULLETIN
    21. Rothman, RB; Carroll, FI
      Opportunities for medication development in obesity

      DRUG DEVELOPMENT RESEARCH
    22. Rothman, RB; Baumann, MH
      Neurochemical mechanisms of phentermine and fenfluramine: Therapeutic and adverse effects

      DRUG DEVELOPMENT RESEARCH
    23. Zhang, Y; Rothman, RB; Dersch, CM; de Costa, BR; Jacobson, AE; Rice, KC
      Synthesis and transporter binding properties of bridged piperazine analogues of 1-{2-[bis(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine (GBR 12909)

      JOURNAL OF MEDICINAL CHEMISTRY
    24. Gu, XH; Yu, H; Jacobson, AE; Rothman, RB; Dersch, CM; George, C; Flippen-Anderson, JL; Rice, KC
      Design, synthesis, and monoamine transporter binding site affinities of methoxy derivatives of indatraline

      JOURNAL OF MEDICINAL CHEMISTRY
    25. Furness, MS; Zhang, XY; Coop, A; Jacobson, AE; Rothman, RB; Dersch, CM; Xu, H; Porreca, F; Rice, KC
      Probes for narcotic receptor-mediated phenomena. 27. Synthesis and pharmacological evaluation of selective delta-opioid receptor agonists from 4-[(alpha R)-alpha-(2S,5R)-4-substituted-2,5-dimethyl-1-piperazinyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomers

      JOURNAL OF MEDICINAL CHEMISTRY
    26. Rothman, RB
      The age-adjusted mortality rate from primary pulmonary hypertension, in age range 20 to 54 years, did not increase during the years of peak "Phen/Fen" use

      CHEST
    27. Rothman, RB; Baumann, MH; Savage, JE; Rauser, L; McBride, A; Hufeisen, SJ; Roth, BL
      Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications

      CIRCULATION
    28. Rothman, RB; Redmon, JB; Bantle, JP
      Phentermine's effect on serotonin in plasma? Reply

      AMERICAN JOURNAL OF CARDIOLOGY
    29. Rothman, RB; Redmon, JB; Raatz, SK; Kwong, CA; Swanson, JE; Bantle, JP
      Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin

      AMERICAN JOURNAL OF CARDIOLOGY
    30. Coop, A; Pinto, J; Wang, LJ; McCullough, K; Rothman, RB; Dersch, C; Jacobson, AE; Rice, KC
      Delta opioid binding selectivity of 3-ether analogs of naltrindole

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    31. Thomas, JB; Atkinson, RN; Herault, XM; Rothman, RB; Mascarella, SW; Dersch, CM; Xu, H; Horel, RB; Carroll, FI
      Optically pure (-)-4-[(N-allyl-3-methyl-4-piperidinyl)phenyl-amino]-N,N-diethylbenzamide displays selective binding and full agonist activity for thedelta opioid receptor

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    32. Thomas, JB; Herault, XM; Rothman, RB; Burgess, JP; Mascarella, SW; Xu, H; Horel, RB; Dersch, CM; Carroll, FI
      (+/-)-4-[(N-allyl-cis-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide displays selective binding for the delta opiod receptor

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    33. Heyliger, SO; Jackson, C; Rice, KC; Rothman, RB
      Opioid peptide receptor studies. 10. Nor-BNI differentially inhibits kappareceptor agonist-induced G-protein activation in the guinea pig caudate: Further evidence of kappa receptor heterogeneity

      SYNAPSE
    34. Romero, DV; Partilla, JS; Zheng, QX; Heyliger, SO; Ni, Q; Rice, KC; Lai, J; Rothman, RB
      Opioid peptide receptor studies. 12. Buprenorphine is a potent and selective mu/kappa antagonist in the [S-35]-GTP-gamma-S functional binding assay

      SYNAPSE
    35. Villemagne, VL; Wong, DF; Yokoi, F; Stephane, M; Rice, KC; Matecka, D; Clough, DJ; Dannals, RF; Rothman, RB
      GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [C-11]raclopride continuous infusion PET scans

      SYNAPSE
    36. Rothman, RB; Baumann, MH; Dersch, CM; Appel, J; Houghten, RA
      Discovery of novel peptidic dopamine transporter ligands by screening a positional scanning combinatorial hexapeptide library

      SYNAPSE
    37. Rothman, RB
      Retraction and apology: Is phentermine an inhibitor of monoamine oxidase?

      SYNAPSE
    38. Rothman, RB
      Is phentermine an inhibitor of monoamine oxidase? A critical appraisal

      SYNAPSE
    39. Xu, H; Lu, YF; Partilla, JS; Zheng, QX; Wang, JB; Brine, GA; Carroll, FI; Rice, KC; Chen, KX; Chi, ZQ; Rothman, RB
      Opioid peptide receptor studies, 11: Involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligands

      SYNAPSE
    40. Villemagne, VL; Rothman, RB; Yokoi, F; Rice, KC; Matecka, D; Dannals, RF; Wong, DF
      Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [C-11] WIN35,428 PET scans

      SYNAPSE
    41. Goodman, CB; Heyliger, S; Emilien, B; Partilla, JS; Yang, HYT; Lee, CH; Cadet, JL; Rothman, RB
      Chronic exposure to antibodies directed against anti-opiate peptides alterdelta-opioid receptor levels

      PEPTIDES
    42. Donovan, DM; Miner, LL; Perry, MP; Revay, RS; Sharpe, LG; Przedborski, S; Kostic, V; Philpot, RM; Kirstein, CL; Rothman, RB; Schindler, CW; Uhl, GR
      Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression

      MOLECULAR BRAIN RESEARCH
    43. Brady, LS; Herkenham, M; Rothman, RB; Partilla, JS; Konig, M; Zimmer, AM; Zimmer, A
      Region-specific up-regulation of opioid receptor binding in enkephalin knockout mice

      MOLECULAR BRAIN RESEARCH
    44. Rothman, RB
      Does phentermine inhibit monoamine oxidase?

      LANCET
    45. Wojnicki, FHE; Rothman, RB; Rice, KC; Glowa, JR
      Effects of phentermine on responding maintained under multiple fixed-ratioschedules of food and cocaine presentation in the rhesus monkey

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    46. Coop, A; Rothman, RB; Dersch, C; Partilla, J; Porreca, F; Davis, P; Jacobson, AE; Rice, KC
      delta opioid affinity and selectivity of 4-hydroxy-3-methoxyindolomorphinan analogues related to naltrindole

      JOURNAL OF MEDICINAL CHEMISTRY
    47. Zhang, XY; Rice, KC; Calderon, SN; Kayakiri, H; Smith, L; Coop, A; Jacobson, AE; Rothman, RB; Davis, P; Dersch, CM; Porreca, F
      Probes for narcotic receptor mediated phenomena. 26. Synthesis and biological evaluation of diarylmethylpiperazines and diarylmethylpiperidines as novel, nonpeptidic delta opioid receptor ligands

      JOURNAL OF MEDICINAL CHEMISTRY
    48. Lewis, DB; Matecka, D; Zhang, Y; Hsin, LW; Dersch, CM; Stafford, D; Glowa, JR; Rothman, RB; Rice, KC
      Oxygenated analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents

      JOURNAL OF MEDICINAL CHEMISTRY
    49. Ananthan, S; Kezar, HS; Carter, RL; Saini, SK; Rice, KC; Wells, JL; Davis, P; Xu, H; Dersch, CM; Bilsky, EJ; Porreca, F; Rothman, RB
      Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans

      JOURNAL OF MEDICINAL CHEMISTRY
    50. Rothman, RB; Ayestas, MA; Dersch, CM; Baumann, MH
      Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates - Implications for primary pulmonary hypertension

      CIRCULATION
    51. KUBOTA H; ROTHMAN RB; DERSCH C; MCCULLOUGH K; PINTO J; RICE KC
      SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 3-SUBSTITUTED 3-DESOXYNALTRINDOLE DERIVATIVES

      Bioorganic & medicinal chemistry letters
    52. Thomas, JB; Mascarella, SW; Burgess, JP; Xu, H; McCullough, KB; Rothman, RB; Flippen-Anderson, JL; George, CF; Cantrell, BE; Zimmerman, DM; Carroll, FY
      N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methylbenzo[g]isoquinolines are opioid receptor pure antagonists

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    53. REA WP; ROTHMAN RB; SHIPPENBERG TS
      EVALUATION OF THE CONDITIONED REINFORCING EFFECTS OF PHENTERMINE AND FENFLURAMINE IN THE RAT - CONCORDANCE WITH CLINICAL-STUDIES

      Synapse
    54. ROTHMAN RB; SILVERTHORN ML; GLOWA JR; MATECKA D; RICE KC; CARROLL FI; PARTILLA JS; UHL GR; VANDENBERGH DJ; DERSCH CM
      STUDIES OF THE BIOGENIC-AMINE TRANSPORTERS - VII - CHARACTERIZATION OF A NOVEL COCAINE BINDING-SITE IDENTIFIED WITH [I-125] RTI-55 IN MEMBRANES PREPARED FROM HUMAN, MONKEY AND GUINEA-PIG CAUDATE

      Synapse
    55. BAUMANN MH; ROTHMAN RB
      COMBINED PHENTERMINE FENFLURAMINE ADMINISTRATION AND CENTRAL SEROTONIN NEURONS/

      Synapse
    56. LU YF; XU H; LIUCHEN LY; CHEN CG; PARTILLA JS; BRINE GA; CARROLL FI; RICE KC; LAI J; PORRECA F; SADEE W; ROTHMAN RB
      OPIOID PEPTIDE RECEPTOR STUDIES - 7 - THE METHYLFENTANYL CONGENER RTI-4614-4 AND ITS 4 ENANTIOMERS BIND TO DIFFERENT DOMAINS OF THE RAT MU-OPIOID RECEPTOR

      Synapse
    57. BAUMANN MH; AYESTAS MA; ROTHMAN RB
      FUNCTIONAL CONSEQUENCES OF CENTRAL SEROTONIN DEPLETION PRODUCED BY REPEATED FENFLURAMINE ADMINISTRATION IN

      The Journal of neuroscience
    58. NI Q; XU H; PARTILLA JS; RICE KC; MATECKA D; CALDERON SN; PORRECA F; LAI J; SCHMIDHAMMER H; KRASSNIG R; ROTHMAN RB
      OPIOID PEPTIDE RECEPTOR STUDIES - 9 - IDENTIFICATION OF A NOVEL NON-MU-LIKE NON-DELTA-LIKE OPIOID PEPTIDE BINDING-SITE IN RAT-BRAIN

      Peptides (New York, N.Y. 1980)
    59. HEYLIGER SO; PAYZA K; ROTHMAN RB
      THE EFFECT OF FMRFAMIDE ANALOGS ON [S-35] GTP-GAMMA-S STIMULATION IN SQUID OPTIC LOBES

      Peptides
    60. XU H; LU YF; PARTILLA JS; PINTO J; CALDERON SN; MATECKA D; RICE KC; LAI J; PORRECA F; ANANTHAN S; ROTHMAN RB
      OPIOID PEPTIDE RECEPTOR STUDIES .8. ONE OF THE MOUSE-BRAIN DELTA(NCX)BINDING-SITES IS SIMILAR TO THE CLONED MOUSE OPIOID DELTA-RECEPTOR - FURTHER EVIDENCE FOR HETEROGENEITY OF DELTA-OPIOID RECEPTORS

      Peptides
    61. Goodman, CB; Heyliger, S; Emilien, B; Partilla, JS; Yang, HYT; Lee, CH; Cadet, JL; Rothman, RB
      Regulation of mu binding sites after chronic administration of antibodies directed against specific anti-opiate peptides

      PEPTIDES
    62. VILLEMAGNE VL; ROTHMAN RB; YOKOI F; CLOUGH D; RICE KC; MATECKA D; STEPHANE M; WONG DF
      INHIBITION OF AMPHETAMINE-INDUCED DOPAMINE RELEASE BY GBR-12909

      The Journal of nuclear medicine
    63. OHUOHA DC; SCHINDLER CW; ROTHMAN RB
      SEROTONIN-4 RECEPTOR ANTAGONISTS REVERSE COCAINE-INDUCED CARDIAC-ARRHYTHMIA

      Life sciences (1973)
    64. THOMAS JB; ZHENG XL; MASCARELLA SW; ROTHMAN RB; DERSCH CM; PARTILLA JS; FLIPPENANDERSON JL; GEORGE CF; CANTRELL BE; ZIMMERMAN DM; CARROLL FI
      N-SUBSTITUTED 9-BETA-METHYL-5-(3-HYDROXYPHENYL)MORPHANS ARE OPIOID RECEPTOR PURE ANTAGONISTS

      Journal of medicinal chemistry
    65. ANANTHAN S; JOHNSON CA; CARTER RL; CLAYTON SD; RICE KC; XU H; DAVIS P; PORRECA F; ROTHMAN RB
      SYNTHESIS, OPIOID RECEPTOR-BINDING, AND BIOASSAY OF NALTRINDOLE ANALOGS SUBSTITUTED IN THE INDOLIC BENZENE MOIETY

      Journal of medicinal chemistry
    66. THOMAS JB; MASCARELLA SW; ROTHMAN RB; PARTILLA JS; XU H; MCCULLOUGH KB; DERSCH CN; CANTRELL BE; ZIMMERMAN DM; CARROLL FI
      INVESTIGATION OF THE N-SUBSTITUENT CONFORMATION GOVERNING POTENCY ANDMU-RECEPTOR SUBTYPE-SELECTIVITY IN (-(3R,4R)-DIMETHYL-4-(3-HYDROXYPHENYL)PIPERIDINE OPIOID ANTAGONISTS())

      Journal of medicinal chemistry
    67. Thomas, JB; Fall, MJ; Cooper, JB; Rothman, RB; Mascarella, SW; Xu, H; Partilla, JS; Dersch, CM; McCullough, KB; Cantrell, BE; Zimmerman, DM; Carroll, FI
      Identification of an opioid kappa receptor subtype-selective N-substituentfor (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine

      JOURNAL OF MEDICINAL CHEMISTRY
    68. BAUMANN MH; ROTHMAN RB
      ALTERATIONS IN SEROTONERGIC RESPONSIVENESS DURING COCAINE WITHDRAWAL IN RATS - SIMILARITIES TO MAJOR DEPRESSION IN HUMANS

      Biological psychiatry
    69. BURGESS K; LI W; LINTHICUM DS; NI Q; PLEDGER D; ROTHMAN RB; SHITANGKOON A
      LIBRARIES OF OPIATE AND ANTI-OPIATE PEPTIDOMIMETICS CONTAINING 2,3-METHANOLEUCINE

      Bioorganic & medicinal chemistry
    70. GLOWA JR; RICE KC; MATECKA D; ROTHMAN RB
      PHENTERMINE FENFLURAMINE DECREASES COCAINE SELF-ADMINISTRATION IN RHESUS-MONKEYS/

      NeuroReport
    71. ROTHMAN RB; BAUMANN MH
      UNTITLED

      Journal of substance abuse treatment
    72. OHUOHA DC; MAXWELL JA; THOMSON LE; CADET JL; ROTHMAN RB
      EFFECT OF DOPAMINE-RECEPTOR ANTAGONISTS ON COCAINE SUBJECTIVE EFFECTS- A NATURALISTIC CASE-STUDY

      Journal of substance abuse treatment
    73. STALEY JK; ROTHMAN RB; RICE KC; PARTILLA J; MASH DC
      KAPPA(2) OPIOID RECEPTORS IN LIMBIC AREAS OF THE HUMAN BRAIN ARE UP-REGULATED BY COCAINE IN FATAL OVERDOSE VICTIMS

      The Journal of neuroscience
    74. VILLEMAGNE VL; ROTHMAN RB; YOKOI F; FINLEY P; RICE KC; CHEN A; MATECKA D; RAVERT HT; MATHEWS WB; MUSACHIO JL; DANNALS RF; WONG DF
      SUBSTANTIAL OCCUPANCY OF DOPAMINE TRANSPORTERS BY GBR12909, A POTENTIAL TREATMENT AGENT FOR COCAINE ADDICTION, AS MEASURED BY PET

      The Journal of nuclear medicine
    75. ROTHMAN RB
      BRAIN-SEROTONIN NEUROTOXICITY AND FENFLURAMINE AND DEXFENFLURAMINE

      JAMA, the journal of the American Medical Association
    76. CALDERON SN; RICE KC; ROTHMAN RB; PORRECA F; FLIPPENANDERSON JL; KAYAKIRI H; XU H; BECKETTS K; SMITH LE; BILSKY EJ; DAVIS P; HORVATH R
      PROBES FOR NARCOTIC RECEPTOR-MEDIATED PHENOMENA .23. SYNTHESIS, OPIOID RECEPTOR-BINDING, AND BIOASSAY OF THE HIGHLY SELECTIVE DELTA-AGONISTPIPERAZINYL)-3-METHOXYBENZYL]-N,N-DIETHYLBENZAMIDE (SNC-80) AND RELATED NOVEL NONPEPTIDE DELTA-OPIOID RECEPTOR LIGANDS())

      Journal of medicinal chemistry
    77. MATECKA D; LEWIS D; ROTHMAN RB; DERSCH CM; WOJNICKI FHE; GLOWA JR; DEVRIES AC; PERT A; RICE KC
      HETEROAROMATIC ANALOGS OF PHENYLMETHOXY)ETHYL]-4-(3-PHENYLPROPYL)PIPERAZINES AND HENYL)METHOXY]ETHYL]-4-(3-PHENYLPROPYL)PIPERAZINES (GBR-12935 AND GBR-12909) AS HIGH-AFFINITY DOPAMINE REUPTAKE INHIBITORS

      Journal of medicinal chemistry
    78. KATSURA Y; ZHANG XY; HOMMA K; RICE KC; CALDERON SN; ROTHMAN RB; YAMAMURA HI; DAVIS P; FLIPPENANDERSON JL; XU H; BECKETTS K; FOLTZ EJ; PORRECA F
      PROBES FOR NARCOTIC RECEPTOR-MEDIATED PHENOMENA .25. SYNTHESIS AND EVALUATION OF N-ALKYL-SUBSTITUTED (ALPHA-PIPERAZINYLBENZYL)BENZAMIDES ASNOVEL, HIGHLY SELECTIVE DELTA-OPIOID RECEPTOR AGONISTS

      Journal of medicinal chemistry
    79. BRINE GA; STARK PA; LIU Y; CARROLL FI; SINGH P; XU H; ROTHMAN RB
      ENANTIOMERS OF DIASTEREOISOMERIC LETHYL)-3-METHYL-4-PIPERIDYL]-N-PHENYLPROPANAMIDES - SYNTHESIS, X-RAY-ANALYSIS, AND BIOLOGICAL-ACTIVITIES (VOL 38, PG 3652, 1995)

      Journal of medicinal chemistry
    80. GORELICK DA; ROTHMAN RB
      STIMULANT SENSITIZATION IN HUMANS

      Biological psychiatry
    81. ROTHMAN RB; AYESTAS M; GLOWA JR; BAUMANN MH
      PHENTERMINE REDUCES COCAINE-INDUCED INCREASES IN BRAIN DA AND COCAINESELF-ADMINISTRATION

      Biological psychiatry
    82. BAUMANN MH; AYESTAS MA; DERSCH CM; BROCKINGTON A; ROTHMAN RB
      ANORECTIC AMPHETAMINES DIFFERENTIALLY AFFECT MONOAMINE FUNCTION - THERAPEUTIC IMPLICATIONS

      Biological psychiatry
    83. OHUOHA DC; BROCKINGTON A; ELMER G; ROTHMAN RB
      SEROTONIN-4 ANTAGONISTS (GR113808A AND GR125487D) AND COCAINE TOXICITY

      Biological psychiatry
    84. SHOAIB MI; BAUMANN MH; ROTHMAN RB; GOLDBERG SR; SCHINDLER CW
      BEHAVIORAL AND NEUROCHEMICAL CHARACTERISTICS OF PHENTERMINE AND FENFLURAMINE ADMINISTERED SEPARATELY AND AS A MIXTURE IN RATS

      Psychopharmacology
    85. KAYAKIRI H; JACOBSON AE; RICE KC; ROTHMAN RB; XU H; FLIPPENANDERSON JL; GEORGE C; ACETO MD; BOWMAN ER; HARRIS LS; MAY EL; PARTILLA JS; BECKETTS K
      PROBES FOR NARCOTIC RECEPTOR-MEDIATED PHENOMENA .24. SYNTHESIS, SINGLE-CRYSTAL X-RAY ANALYSES, IN-VITRO AND IN-VIVO PROPERTIES OF -3,14-DIHYDROXY-17-METHYL-4,5-ALPHA-EPOXYMORPHINAN AND -3,14-DIHYDROXY-17-METHYL-4,5-ALPHA-EPOXYMORPHINAN

      Medicinal chemistry research
    86. ROTHMAN RB; AYESTAS M; BAUMANN MH
      PHENTERMINE PRETREATMENT ANTAGONIZES THE COCAINE-INDUCED RISE IN MESOLIMBIC DOPAMINE

      NeuroReport
    87. BRAUER LH; JOHANSON CE; SCHUSTER CR; ROTHMAN RB; DEWIT H
      EVALUATION OF PHENTERMINE AND FENFLURAMINE, ALONE AND IN COMBINATION,IN NORMAL, HEALTHY-VOLUNTEERS

      Neuropsychopharmacology
    88. BAUMANN MH; SCHUSTER CR; ROTHMAN RB
      EFFECTS OF PHENTERMINE AND COCAINE ON FENFLURAMINE-INDUCED DEPLETION OF SEROTONIN IN MOUSE-BRAIN

      Drug and alcohol dependence
    89. CALDERON SN; BERTHA CM; GUTKIND JS; XU H; PARTILLA JS; ROTHMAN RB; RICE KC
      PROBES FOR NARCOTIC RECEPTOR-MEDIATED PHENOMENA .22. SYNTHESIS AND CHARACTERIZATION OF OPTICALLY PURE [H-3] IPERAZINYL)-3-METHOXYBENZYL]-N,N-DIETHYLBENZAMIDE, [H-3] SNC-121, A NOVEL HIGH-AFFINITY AND SELECTIVELIGAND FOR DELTA-OPIOID RECEPTORS())

      Journal of labelled compounds & radiopharmaceuticals
    90. GOODMAN CB; EMILIEN B; BECKETTS K; CADET JL; ROTHMAN RB
      DOWN-REGULATION OF MU-OPIOID BINDING-SITES FOLLOWING CHRONIC ADMINISTRATION OF NEUROPEPTIDE FF (NPFF) AND MORPHINE

      Peptides
    91. ROTHMAN RB
      TREATMENT OF A 4-YEAR-OLD BOY WITH ADHD WITH THE DOPAMINE RELEASER PHENTERMINE

      The Journal of clinical psychiatry
    92. ROTHMAN RB
      SMOKING CESSATION IN A PATIENT BEING TREATED WITH FENFLURAMINE PLUS PHENTERMINE FOR SIMPLE OBESITY

      The Journal of clinical psychiatry
    93. PICKWORTH WB; BAUMANN MH; FANT RV; ROTHMAN RB; HENNINGFIELD JE
      ENDOCRINE RESPONSES DURING ACUTE NICOTINE WITHDRAWAL

      Pharmacology, biochemistry and behavior
    94. ELMER GI; BROCKINGTON A; GORELICK DA; CARROL FI; RICE KC; MATECKA D; GOLDBERG SR; ROTHMAN RB
      COCAINE CROSS-SENSITIZATION TO DOPAMINE UPTAKE INHIBITORS - UNIQUE EFFECTS OF GBR12909

      Pharmacology, biochemistry and behavior
    95. ELMER GI; GORELICK DA; GOLDBERG SR; ROTHMAN RB
      ACUTE SENSITIVITY VS CONTEXT-SPECIFIC SENSITIZATION TO COCAINE AS A FUNCTION OF GENOTYPE

      Pharmacology, biochemistry and behavior
    96. BAUMANN MH; ROTHMAN RB
      CHRONIC COCAINE EXPOSURE POTENTIATES PROLACTIN AND HEAD SHAKE RESPONSES TO 5-HT2 RECEPTOR STIMULATION IN RATS

      Neuropharmacology
    97. STALEY JK; ROTHMAN RB; RICE KC; SANCHEZRAMOS J; WEINER WJ; MASH DC
      MAPPING THE DISTRIBUTION OF KAPPA-2 OPIOID RECEPTORS IN PARKINSONS-DISEASE - A LIGAND-BINDING AND AUTORADIOGRAPHY STUDY

      Neurology
    98. KNAPP RJ; SANTORO G; DELEON IA; LEE KB; EDSALL SA; WAITE S; MALATYNSKA E; VARGA E; CALDERON SN; RICE KC; ROTHMAN RB; PORRECA F; ROESKE WR; YAMAMURA HI
      STRUCTURE-ACTIVITY-RELATIONSHIPS FOR SNC80 AND RELATED-COMPOUNDS AT CLONED HUMAN DELTA-OPIOID AND MU-OPIOID RECEPTORS

      The Journal of pharmacology and experimental therapeutics
    99. BILSKY EJ; BERNSTEIN RN; HRUBY VJ; ROTHMAN RB; LAI J; PORRECA F
      CHARACTERIZATION OF ANTINOCICEPTION TO OPIOID RECEPTOR-SELECTIVE AGONISTS AFTER ANTISENSE OLIGODEOXYNUCLEOTIDE-MEDIATED KNOCK-DOWN OF OPIOID RECEPTORS IN-VIVO

      The Journal of pharmacology and experimental therapeutics
    100. GLOWA JR; FANTEGROSSI WE; LEWIS DB; MATECKA D; RICE KC; ROTHMAN RB
      SUSTAINED DECREASE IN COCAINE-MAINTAINED RESPONDING IN RHESUS-MONKEYSWITH HOXY]ETHYL]4-(3-HYDROXY-3-PHENYLPROPYL)PIPERAZINYL DECANOATE, A LONG-ACTING ESTER DERIVATIVE OF GBR-12909

      Journal of medicinal chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 14:33:25